MedTrace Logo

Prospective Regional Epilepsy Database

NCT04559919 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-06-13

No results posted yet for this study

Summary

PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.

Conditions

Interventions

OTHER

Seizure status

We will collect information on first seizure ever, last seizure ever, number of seizure in last two months.

DIAGNOSTIC_TEST

Tests

We will collect results from imaging, electroencephalogram, and laboratory tests.

OTHER

Epilepsy

We will collect information on risk factors of epilepsy, cause of epilepsy, epilepsy type/syndrome, medications tried, if the epilepsy is drug resistent, side effects of antiepileptic drugs.

OTHER

Demographics and psychosocial

We will collect information on age, sex, date of death if applicable, marital status, education level, income type, driving status, employment, benefits, sick leave, number of household members.

OTHER

Health care

We will collect information on received health care; visit dates, caregiver, dispensation dates of antiepileptic drugs

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Johan Zelano, MD PhD · Sahlgrenska University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-27
Primary Completion
2031-12-31
Completion
2031-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559919 on ClinicalTrials.gov